# Sodium nitroprusside

NDC: 67457-999
Generic name: Sodium nitroprusside
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20201005
Marketing ended: 20270831
FDA application: ANDA210763

## Active ingredients

- SODIUM NITROPRUSSIDE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-999"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-999
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a8999285-16b1-473d-8e92-684f581534f6